Literature DB >> 31361881

ASHP national survey of pharmacy practice in hospital settings: Monitoring and patient education-2018.

Craig A Pedersen1, Philip J Schneider2, Michael C Ganio3, Douglas J Scheckelhoff4.   

Abstract

PURPOSE: The results of the 2018 ASHP national survey of pharmacy practice in hospital settings are presented.
METHODS: Pharmacy directors at 4,897 general and children's medical-surgical hospitals in the United States were surveyed using a mixed-mode method of contact by mail and email. Survey completion was online using Qualtrics. IMS Health supplied data on hospital characteristics; the survey sample was drawn from IMS's hospital database.
RESULTS: The response rate was 16.6%. The percentage of hospitals that routinely have pharmacists assigned to provide drug therapy management has increased. Transitions-of-care processes have generally increased over the last 6 years. The percentage of hospitals with pharmacists in a wide variety of clinic types and clinical practice areas has increased over the last 2 years. Opioid stewardship programs are emerging in many U.S. hospitals, with pharmacists participating or taking the lead in program implementation. Outsourcing of compounded sterile product preparation is common. The proportion of hospitals not using any technology when compounding sterile preparations has declined. Pharmacy departments commonly track and monitor trends for administrative, operational, quality, and outcome metrics.
CONCLUSION: Pharmacists continue to improve drug therapy monitoring for patients in U.S. hospitals. They are also responding to public health issues related to medication use. These advancements include taking an active role in opioid stewardship programs, safe compounding of sterile medications for patients, and reducing the need for hospital-based care. © American Society of Health-System Pharmacists 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  drug compounding; drug monitoring; hospital; medication therapy management; pharmacovigilance; pharmacy service; quality improvement

Year:  2019        PMID: 31361881     DOI: 10.1093/ajhp/zxz099

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  5 in total

1.  Medication regimen complexity vs patient acuity for predicting critical care pharmacist interventions.

Authors:  Susan E Smith; Rachel Shelley; Andrea Sikora
Journal:  Am J Health Syst Pharm       Date:  2022-04-01       Impact factor: 2.637

2.  Impact of pharmacy-supported interventions on proportion of patients receiving non-indicated acid suppressive therapy upon discharge: A systematic review and meta-analysis.

Authors:  Devada Singh-Franco; David R Mastropietro; Miriam Metzner; Michael D Dressler; Amneh Fares; Melinda Johnson; Daisy De La Rosa; William R Wolowich
Journal:  PLoS One       Date:  2020-12-03       Impact factor: 3.240

3.  Pharmacy practice in hospital settings in GCC countries: Prescribing and transcribing.

Authors:  Ahmed H Al-Jedai; Fowad Khurshid; Ahmed Y Mayet; Hussain A Al-Omar; Sarah S Alghanem; Mohammed S Alsultan
Journal:  Saudi Pharm J       Date:  2021-07-21       Impact factor: 4.330

4.  Improving the Experience of Providing Care in Community-Based Pharmacies.

Authors:  Jon C Schommer; SuHak Lee; Caroline A Gaither; Nancy A Alvarez; April M Shaughnessy
Journal:  Pharmacy (Basel)       Date:  2022-06-22

5.  Stepwise Development and Yearlong Assessment of a Pharmacist-Driven Molecular Rapid Diagnostic Test Result Service for Bloodstream Infections.

Authors:  Andrew Ticcioni; Kyle Piscitello; Matthew Bjornstad; Katie Hensley; Jim Davis; Annette Drobac; John Canepa
Journal:  Innov Pharm       Date:  2021-04-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.